Greenwood D, Edwards R, Brown J, Ridout P
Department of Microbiology, University Hospital, Queen's Medical Centre, GB-Nottingham, UK.
Infection. 1992;20 Suppl 4:S302-4. doi: 10.1007/BF01710019.
Five hundred urinary pathogens, collected from patients of general practitioners and hospital in-patients, were identified and tested for susceptibility to fosfomycin, ampicillin, cephalexin, nalidixic acid, nitrofurantoin, trimethoprim and sulfamethoxazole. Overall, 83% of the isolates were sensitive to fosfomycin, comprising 89% of the out-patient strains and 77% of the in-patient isolates. This degree of sensitivity was similar to that of cephalexin, nalidixic acid and trimethoprim, but higher than that observed with ampicillin, nitrofurantoin and sulfamethoxazole. Fosfomycin generally showed a broad spectrum of activity, but was less active than some other compounds against Klebsiella spp. and streptococci. More than 70% of strains resistant to ampicillin, sulfamethoxazole or trimethoprim were sensitive to fosfomycin indicating that cross resistance is not presently a problem.
从全科医生的患者和住院患者中收集了500株尿路病原体,对其进行鉴定并测试了对磷霉素、氨苄西林、头孢氨苄、萘啶酸、呋喃妥因、甲氧苄啶和磺胺甲恶唑的敏感性。总体而言,83%的分离株对磷霉素敏感,其中门诊菌株占89%,住院分离株占77%。这种敏感程度与头孢氨苄、萘啶酸和甲氧苄啶相似,但高于氨苄西林、呋喃妥因和磺胺甲恶唑。磷霉素通常显示出广泛的活性谱,但对克雷伯菌属和链球菌的活性低于其他一些化合物。超过70%对氨苄西林、磺胺甲恶唑或甲氧苄啶耐药的菌株对磷霉素敏感,这表明目前不存在交叉耐药问题。